Evotec SE
EVOTF
$8.27
-$0.9494-10.30%
| Weiss Ratings | EVOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | EVOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | EVOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.12 | |||
| Price History | EVOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | -10.30% | |||
| 90-Day Total Return | -12.39% | |||
| Year to Date Total Return | -10.30% | |||
| 1-Year Total Return | -40.20% | |||
| 2-Year Total Return | -59.95% | |||
| 3-Year Total Return | -71.96% | |||
| 5-Year Total Return | -59.66% | |||
| 52-Week High % Change | -34.36% | |||
| 52-Week Low % Change | 38.30% | |||
| Price | EVOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $12.60 | |||
| 52-Week Low Price | $5.98 | |||
| 52-Week Low Price (Date) | Aug 07, 2024 | |||
| 52-Week High Price (Date) | Nov 14, 2024 | |||
| Valuation | EVOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.06B | |||
| Enterprise Value | 1.24B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.05 | |||
| Earnings Per Share Growth | 82.67% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.74 | |||
| Price/Book (Q) | 1.36 | |||
| Enterprise Value/Revenue (TTM) | 1.93 | |||
| Price | $8.27 | |||
| Enterprise Value/EBITDA (TTM) | 50.67 | |||
| Enterprise Value/EBIT | -27.01 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | EVOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 177.35M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | EVOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 49 40 560 81 0 | |||
| Address | -- | |||
| Website | www.evotec.com | |||
| Country | Germany | |||
| Year Founded | 1993 | |||
| Profitability | EVOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -7.16% | |||
| Profit Margin | -22.02% | |||
| Management Effectiveness | EVOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -1.64% | |||
| Return on Equity | -- | |||
| Income Statement | EVOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 842.61M | |||
| Total Revenue (TTM) | 842.61M | |||
| Revenue Per Share | $4.75 | |||
| Gross Profit (TTM) | 115.33M | |||
| EBITDA (TTM) | 32.17M | |||
| EBIT (TTM) | -60.35M | |||
| Net Income (TTM) | -185.56M | |||
| Net Income Avl. to Common (TTM) | -185.56M | |||
| Total Revenue Growth (Q YOY) | -4.85% | |||
| Earnings Growth (Q YOY) | -2.77% | |||
| EPS Diluted (TTM) | -1.05 | |||
| EPS Diluted Growth (Q YOY) | -2.55% | |||
| Balance Sheet | EVOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 338.25M | |||
| Cash Per Share (Q) | $1.91 | |||
| Total Current Assets (Q) | 778.61M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.08B | |||
| Current Ratio (Q) | 2.093 | |||
| Book Value Per Share (Q) | $6.09 | |||
| Total Assets (Q) | 2.22B | |||
| Total Current Liabilities (Q) | 372.09M | |||
| Total Debt (Q) | 524.26M | |||
| Total Liabilities (Q) | 1.14B | |||
| Total Common Equity (Q) | 1.08B | |||
| Cash Flow | EVOTF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -124.06M | |||
| Cash from Financing (TTM) | -122.90M | |||
| Net Change in Cash (TTM) | -289.08M | |||
| Levered Free Cash Flow (TTM) | -128.12M | |||
| Cash from Operations (TTM) | -36.86M | |||
